Cite
HARVARD Citation
Dudnik, E. et al. (2021). Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence. International journal of cancer. 148 (5), pp. 1183-1191. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dudnik, E. et al. (2021). Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence. International journal of cancer. 148 (5), pp. 1183-1191. [Online].